Study on Absorption, Distribution and Excretion of a New Candidate Compound XYY-CP1106 against Alzheimer’s Disease in Rats by LC-MS/MS
XYY-CP1106, a candidate compound synthesized from a hybrid of hydroxypyridinone and coumarin, has been shown to be remarkably effective in treating Alzheimer’s disease. A simple, rapid and accurate high-performance liquid chromatography coupled with the triple quadrupole mass spectrometer (LC-MS/MS)...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-03-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/28/5/2377 |
| _version_ | 1797614716424552448 |
|---|---|
| author | Zili Guo Bianbian Gao Miaoliang Fan Lisha Chen Changjun Zhang Xianrui Liang Weike Su Yuanyuan Xie |
| author_facet | Zili Guo Bianbian Gao Miaoliang Fan Lisha Chen Changjun Zhang Xianrui Liang Weike Su Yuanyuan Xie |
| author_sort | Zili Guo |
| collection | DOAJ |
| description | XYY-CP1106, a candidate compound synthesized from a hybrid of hydroxypyridinone and coumarin, has been shown to be remarkably effective in treating Alzheimer’s disease. A simple, rapid and accurate high-performance liquid chromatography coupled with the triple quadrupole mass spectrometer (LC-MS/MS) method was established in this study to elucidate the pharmacokinetics of XYY-CP1106 after oral and intravenous administration in rats. XYY-CP1106 was shown to be rapidly absorbed into the blood (<i>T</i><sub>max</sub>, 0.57–0.93 h) and then eliminated slowly (<i>T</i><sub>1/2</sub>, 8.26–10.06 h). Oral bioavailability of XYY-CP1106 was (10.70 ± 1.72)%. XYY-CP1106 could pass through the blood–brain barrier with a high content of (500.52 ± 260.12) ng/g at 2 h in brain tissue. The excretion results showed that XYY-CP1106 was mainly excreted through feces, with an average total excretion rate of (31.14 ± 0.05)% in 72 h. In conclusion, the absorption, distribution and excretion of XYY-CP1106 in rats provided a theoretical basis for subsequent preclinical studies. |
| first_indexed | 2024-03-11T07:16:19Z |
| format | Article |
| id | doaj.art-39aa218031cd47698c3d0591aa0e5a0b |
| institution | Directory Open Access Journal |
| issn | 1420-3049 |
| language | English |
| last_indexed | 2024-03-11T07:16:19Z |
| publishDate | 2023-03-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Molecules |
| spelling | doaj.art-39aa218031cd47698c3d0591aa0e5a0b2023-11-17T08:15:51ZengMDPI AGMolecules1420-30492023-03-01285237710.3390/molecules28052377Study on Absorption, Distribution and Excretion of a New Candidate Compound XYY-CP1106 against Alzheimer’s Disease in Rats by LC-MS/MSZili Guo0Bianbian Gao1Miaoliang Fan2Lisha Chen3Changjun Zhang4Xianrui Liang5Weike Su6Yuanyuan Xie7College of Pharmaceutical Sciences, Key Laboratory of Pharmaceutical Engineering of Zhejiang Province, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, ChinaCollege of Pharmaceutical Sciences, Key Laboratory of Pharmaceutical Engineering of Zhejiang Province, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, ChinaCollege of Pharmaceutical Sciences, Key Laboratory of Pharmaceutical Engineering of Zhejiang Province, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, ChinaCollege of Pharmaceutical Sciences, Key Laboratory of Pharmaceutical Engineering of Zhejiang Province, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, ChinaCollege of Pharmaceutical Sciences, Key Laboratory of Pharmaceutical Engineering of Zhejiang Province, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, ChinaCollege of Pharmaceutical Sciences, Key Laboratory of Pharmaceutical Engineering of Zhejiang Province, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, ChinaCollege of Pharmaceutical Sciences, Key Laboratory of Pharmaceutical Engineering of Zhejiang Province, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, ChinaCollege of Pharmaceutical Sciences, Key Laboratory of Pharmaceutical Engineering of Zhejiang Province, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, ChinaXYY-CP1106, a candidate compound synthesized from a hybrid of hydroxypyridinone and coumarin, has been shown to be remarkably effective in treating Alzheimer’s disease. A simple, rapid and accurate high-performance liquid chromatography coupled with the triple quadrupole mass spectrometer (LC-MS/MS) method was established in this study to elucidate the pharmacokinetics of XYY-CP1106 after oral and intravenous administration in rats. XYY-CP1106 was shown to be rapidly absorbed into the blood (<i>T</i><sub>max</sub>, 0.57–0.93 h) and then eliminated slowly (<i>T</i><sub>1/2</sub>, 8.26–10.06 h). Oral bioavailability of XYY-CP1106 was (10.70 ± 1.72)%. XYY-CP1106 could pass through the blood–brain barrier with a high content of (500.52 ± 260.12) ng/g at 2 h in brain tissue. The excretion results showed that XYY-CP1106 was mainly excreted through feces, with an average total excretion rate of (31.14 ± 0.05)% in 72 h. In conclusion, the absorption, distribution and excretion of XYY-CP1106 in rats provided a theoretical basis for subsequent preclinical studies.https://www.mdpi.com/1420-3049/28/5/2377XYY-CP1106Alzheimer’s diseaseLC-MS/MSpharmacokineticstissue distributionexcretion study |
| spellingShingle | Zili Guo Bianbian Gao Miaoliang Fan Lisha Chen Changjun Zhang Xianrui Liang Weike Su Yuanyuan Xie Study on Absorption, Distribution and Excretion of a New Candidate Compound XYY-CP1106 against Alzheimer’s Disease in Rats by LC-MS/MS Molecules XYY-CP1106 Alzheimer’s disease LC-MS/MS pharmacokinetics tissue distribution excretion study |
| title | Study on Absorption, Distribution and Excretion of a New Candidate Compound XYY-CP1106 against Alzheimer’s Disease in Rats by LC-MS/MS |
| title_full | Study on Absorption, Distribution and Excretion of a New Candidate Compound XYY-CP1106 against Alzheimer’s Disease in Rats by LC-MS/MS |
| title_fullStr | Study on Absorption, Distribution and Excretion of a New Candidate Compound XYY-CP1106 against Alzheimer’s Disease in Rats by LC-MS/MS |
| title_full_unstemmed | Study on Absorption, Distribution and Excretion of a New Candidate Compound XYY-CP1106 against Alzheimer’s Disease in Rats by LC-MS/MS |
| title_short | Study on Absorption, Distribution and Excretion of a New Candidate Compound XYY-CP1106 against Alzheimer’s Disease in Rats by LC-MS/MS |
| title_sort | study on absorption distribution and excretion of a new candidate compound xyy cp1106 against alzheimer s disease in rats by lc ms ms |
| topic | XYY-CP1106 Alzheimer’s disease LC-MS/MS pharmacokinetics tissue distribution excretion study |
| url | https://www.mdpi.com/1420-3049/28/5/2377 |
| work_keys_str_mv | AT ziliguo studyonabsorptiondistributionandexcretionofanewcandidatecompoundxyycp1106againstalzheimersdiseaseinratsbylcmsms AT bianbiangao studyonabsorptiondistributionandexcretionofanewcandidatecompoundxyycp1106againstalzheimersdiseaseinratsbylcmsms AT miaoliangfan studyonabsorptiondistributionandexcretionofanewcandidatecompoundxyycp1106againstalzheimersdiseaseinratsbylcmsms AT lishachen studyonabsorptiondistributionandexcretionofanewcandidatecompoundxyycp1106againstalzheimersdiseaseinratsbylcmsms AT changjunzhang studyonabsorptiondistributionandexcretionofanewcandidatecompoundxyycp1106againstalzheimersdiseaseinratsbylcmsms AT xianruiliang studyonabsorptiondistributionandexcretionofanewcandidatecompoundxyycp1106againstalzheimersdiseaseinratsbylcmsms AT weikesu studyonabsorptiondistributionandexcretionofanewcandidatecompoundxyycp1106againstalzheimersdiseaseinratsbylcmsms AT yuanyuanxie studyonabsorptiondistributionandexcretionofanewcandidatecompoundxyycp1106againstalzheimersdiseaseinratsbylcmsms |